Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of GoodwillAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionDivestmentsExchange Rate EffectFree Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesSales of Property, Plant and EquipmentShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Avanos Medical (AVNS) Cash from Operations (2016 - 2025)

Avanos Medical's Cash from Operations history spans 11 years, with the latest figure at 57900000.0 for Q4 2024.

  • For Q4 2024, Cash from Operations rose 355.91% year-over-year to 57900000.0; the TTM value through Dec 2024 reached 100700000.0, up 210.8%, while the annual FY2025 figure was 74700000.0, 25.82% down from the prior year.
  • Cash from Operations for Q4 2024 was 57900000.0 at Avanos Medical, up from 23000000.0 in the prior quarter.
  • Across five years, Cash from Operations topped out at 57900000.0 in Q4 2024 and bottomed at 8000000.0 in Q1 2024.
  • The 5-year median for Cash from Operations is 14000000.0 (2021), against an average of 15440000.0.
  • The largest annual shift saw Cash from Operations surged 4636.36% in 2021 before it crashed 477.78% in 2023.
  • A 5-year view of Cash from Operations shows it stood at 1100000.0 in 2020, then soared by 4636.36% to 52100000.0 in 2021, then tumbled by 35.32% to 33700000.0 in 2022, then crashed by 62.31% to 12700000.0 in 2023, then soared by 355.91% to 57900000.0 in 2024.
  • Per Business Quant, the three most recent readings for AVNS's Cash from Operations are 57900000.0 (Q4 2024), 23000000.0 (Q3 2024), and 27800000.0 (Q2 2024).